An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia
Clinical trial NCT01175135 · COMPLETED
Trial details
- NCT number
- NCT01175135
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-08-01
- Enrollment
- 259
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.